We asked over 100 industry professionals for their views on the future of the pharma and biopharma industries.

Sitting Down With… Lars Petersen, President and CEO, FUJIFILM Diosynth Biotechnologies

Continuous processing for small molecule products has been a hot topic for years, but where does the industry stand with it today?

Biopharma companies procrastinating on sustainability measures risk falling behind, according to Cytiva’ Global Biopharma Sustainability Review.

A look back at some of the most inspiring quotes from our interviews.

From developments in cell culture media to enhancing the potency of monoclonal antibodies – check out our free eBook.

AstraZeneca’s FluMist is the first flu vaccine to be approved for self-administration.

The analytical complexities that come with oligonucleotide manufacturing are difficult, but not impossible.

Here’s how an mRNA-based approach can overcome the development challenges of designing protein therapeutics.

We look at three recent studies that demonstrate the versatility of hot melt extrusion for developing patient-centric dosage forms.